Skip to main content
BIOX
NASDAQ Industrial Applications And Services

Bioceres Subsidiaries' Collateral Foreclosed for $15M Amidst Disputed Defaults

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$1.3
Mkt Cap
$82.197M
52W Low
$1.17
52W High
$7.438
Market data snapshot near publication time

summarizeSummary

Bioceres Crop Solutions Corp. announced that collateral from its Pro Farm Group subsidiaries was foreclosed and sold for $15 million to noteholders, a transaction the company disputes.


check_boxKey Events

  • UCC Foreclosure Sale

    A UCC foreclosure sale was held on January 20, 2026, concerning collateral pledged by Bioceres' subsidiaries, Pro Farm Group, Inc. and Pro Farm Michigan Manufacturing, LLC, due to alleged defaults on notes.

  • Collateral Acquired by Noteholders' Joint Venture

    PFG Holdings Corp., a joint venture formed by the noteholders, was the sole qualified bidder and acquired the collateral with a credit bid of $15 million in notes held.

  • Company Disputes Foreclosure

    Bioceres Crop Solutions Corp. disputes the alleged defaults that led to the foreclosure and the commercial reasonableness of the sale, reserving all rights and remedies.


auto_awesomeAnalysis

This event signals significant financial distress and potential loss of key assets for Bioceres Crop Solutions Corp. The $15 million foreclosure sale, representing a substantial portion of the company's market capitalization, indicates a material impact on its financial health and operational capacity. The company's dispute over the alleged defaults and the commercial reasonableness of the sale suggests ongoing legal battles and uncertainty, which could further impact investor confidence and financial stability. Investors should monitor the outcome of these disputes and assess the long-term implications for the company's asset base and future operations.

At the time of this filing, BIOX was trading at $1.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $82.2M. The 52-week trading range was $1.17 to $7.44. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BIOX - Latest Insights

BIOX
Apr 28, 2026, 11:23 AM EDT
Source: Reuters
Importance Score:
8
BIOX
Apr 28, 2026, 11:11 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
BIOX
Mar 24, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
BIOX
Mar 17, 2026, 9:16 AM EDT
Filing Type: 6-K
Importance Score:
9
BIOX
Mar 13, 2026, 5:23 PM EDT
Filing Type: 6-K
Importance Score:
10
BIOX
Mar 13, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
BIOX
Mar 05, 2026, 4:10 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
BIOX
Feb 05, 2026, 5:49 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
BIOX
Jan 21, 2026, 6:19 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
BIOX
Jan 20, 2026, 4:02 PM EST
Filing Type: 6-K
Importance Score:
9